{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:47:19Z","timestamp":1786981639339,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03086-2","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:48:55Z","timestamp":1743641335000},"page":"497-502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Khorana risk score in lung cancer patients treated with immune checkpoint inhibitors: a real-world study"],"prefix":"10.1007","volume":"58","author":[{"given":"Junmin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ashraf","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria Diaz","family":"Abram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Fai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yu","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Han","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"4","key":"3086_CR1","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/ATVBAHA.120.314378","volume":"41","author":"SP Grover","year":"2021","unstructured":"Grover SP, Hisada YM, Kasthuri RS, Reeves BN, Mackman N (2021) Cancer Therapy-Associated Thromb Arterioscler Thromb Vascular Biology 41(4):1291\u20131305","journal-title":"Cancer Therapy-Associated Thromb Arterioscler Thromb Vascular Biology"},{"issue":"21","key":"3086_CR2","doi-asserted-by":"publisher","first-page":"8062","DOI":"10.1002\/cam4.3437","volume":"9","author":"AA Khorana","year":"2020","unstructured":"Khorana AA, Kuderer NM, McCrae K, Milentijevic D, Germain G, Lalibert\u00e9 F, MacKnight SD, Lefebvre P, Lyman GH, Streiff MB (2020) Cancer associated thrombosis and mortality in patients with cancer stratified by Khorana score risk levels. Cancer Med 9(21):8062\u20138073","journal-title":"Cancer Med"},{"issue":"12","key":"3086_CR3","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1182\/blood.2020007878","volume":"137","author":"F Moik","year":"2021","unstructured":"Moik F, Chan WE, Wiedemann S, Hoeller C, Tuchmann F, Aretin MB, Fuereder T, Z\u00f6chbauer-M\u00fcller S, Preusser M, Pabinger I, Ay C (2021) Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy. Blood 137(12):1669\u20131678","journal-title":"Blood"},{"issue":"2","key":"3086_CR4","doi-asserted-by":"publisher","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN, Esposito J, Claerhout B (2023) A global federated real-world data and analytics platform for research. JAMIA Open 6(2):ooad035","journal-title":"JAMIA Open"},{"issue":"12","key":"3086_CR5","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1111\/jth.15883","volume":"20","author":"TF Overvad","year":"2022","unstructured":"Overvad TF, Skj\u00f8th F, Piazza G, Noble S, Ording AG, Larsen TB, Nielsen PB (2022) The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study. J Thromb Haemostasis: JTH 20(12):2921\u20132929","journal-title":"J Thromb Haemostasis: JTH"},{"key":"3086_CR6","doi-asserted-by":"crossref","unstructured":"Gong J, Drobni ZD, Alvi RM, Murphy SP, Sullivan RJ, Hartmann SE, Gilman HK, Lee H, Zubiri L, Raghu VK, Karp-Leaf RS, Zafar A, Zlotoff DA, Frigault MJ, Reynolds KL, Neilan TG (1990) Immune checkpoint inhibitors for cancer and venous thromboembolic events, European journal of cancer (Oxford, England: 158 (2021) 99\u2013110","DOI":"10.1016\/j.ejca.2021.09.010"},{"issue":"5","key":"3086_CR7","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/jth.15272","volume":"19","author":"O Icht","year":"2021","unstructured":"Icht O, Darzi N, Shimony S, Jacobi O, Reinhorn D, Landman Y, Mutai R, Averbuch I, Shochat T, Spectre G, Raanani P, Rotem O, Dudnik E, Peled N, Zer A, Leader A (2021) Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors. J Thromb Haemostasis: JTH 19(5):1250\u20131258","journal-title":"J Thromb Haemostasis: JTH"},{"issue":"2","key":"3086_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11239-022-02649-x","volume":"54","author":"S Alma","year":"2022","unstructured":"Alma S, Eloi D, L\u00e9a V, Julie C, Val\u00e9rie M, Pierre G, Hilgers W, Philippe G, Christine Z, Philippe D (2022) Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors. J Thromb Thrombolysis 54(2):287\u2013294","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"3086_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1080\/17474086.2023.2276209","volume":"16","author":"X He","year":"2023","unstructured":"He X, Wei SN, Qin WW, Geng N, Li B, Song S, Wang P (2023) Evaluating the effect of immune checkpoint inhibitors on venous thromboembolism in non-small cell lung cancer patients. Expert Rev Hematol 16(12):1135\u20131142","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"3086_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12890-024-03323-z","volume":"24","author":"J Zhang","year":"2024","unstructured":"Zhang J, Xie Y, Yang L, Yang M, Xu R, Liu D (2024) Validation of risk assessment scores in predicting venous thromboembolism in patients with lung cancer receiving immune checkpoint inhibitors. BMC Pulm Med 24(1):507","journal-title":"BMC Pulm Med"},{"issue":"20","key":"3086_CR11","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1182\/bloodadvances.2020003115","volume":"4","author":"FTM Bosch","year":"2020","unstructured":"Bosch FTM, Mulder FI, Kamphuisen PW, Middeldorp S, Bossuyt PM, B\u00fcller HR, van Es N (2020) Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis. Blood Adv 4(20):5215\u20135225","journal-title":"Blood Adv"},{"issue":"12","key":"3086_CR12","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1160\/TH17-02-0134","volume":"117","author":"LH Lee","year":"2017","unstructured":"Lee LH, Gallus A, Jindal R, Wang C, Wu CC (2017) Incidence of venous thromboembolism in Asian populations: A systematic review. Thromb Haemost 117(12):2243\u20132260","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03086-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T22:11:50Z","timestamp":1746051110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03086-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":12,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["3086"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03086-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"10 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"National Cheng Kung University Hospital\u2019s Institutional Review Board (IRB) granted an exemption from approval for the TriNetX database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of competing interest"}}]}}